Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

DJ US Pharmaceuticals Ishares (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 412,101,000
  • Shares Outstanding, K 2,700

Price Performance

See More
Period Period Low Period High Performance
1-Month
141.76 +7.25%
on 02/09/18
166.06 -8.44%
on 01/29/18
-8.75 (-5.44%)
since 01/19/18
3-Month
141.76 +7.25%
on 02/09/18
166.06 -8.44%
on 01/29/18
+1.52 (+1.01%)
since 11/21/17
52-Week
141.76 +7.25%
on 02/09/18
166.06 -8.44%
on 01/29/18
-0.68 (-0.45%)
since 02/21/17

Most Recent Stories

More News
Solid Q4 Earnings Drive Pharma ETF Outlook

Although pharma ETFs saw terrible trading over the past one month in the latest global market rout, the string of earnings beat bolstered confidence in the space.

XPH : 42.89 (-0.12%)
JNJ : 129.91 (-0.73%)
MRK : 54.55 (-0.78%)
PJP : 65.66 (+0.11%)
IHE : 152.04 (-0.24%)
LLY : 77.55 (unch)
PPH : 59.68 (-0.07%)
PFE : 35.76 (-0.69%)
BMY : 66.53 (-1.22%)
FTXH : 22.12 (+1.00%)
Solid Q4 Earnings Drive Pharma ETF Outlook

Although pharma ETFs saw terrible trading over the past one month in the latest global market rout, the string of earnings beat bolstered confidence in the space.

XPH : 42.89 (-0.12%)
JNJ : 129.91 (-0.73%)
MRK : 54.55 (-0.78%)
PJP : 65.66 (+0.11%)
IHE : 152.04 (-0.24%)
LLY : 77.55 (unch)
PPH : 59.68 (-0.07%)
PFE : 35.76 (-0.69%)
BMY : 66.53 (-1.22%)
FTXH : 22.12 (+1.00%)
Healthcare ETFs in Focus Post JNJ Q4 Results

Investors should closely watch the movement of the JNJ following Q4 results and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.

XLV : 84.12 (-0.41%)
VHT : 157.88 (-0.28%)
JNJ : 129.91 (-0.73%)
IHE : 152.04 (-0.24%)
IYH : 177.81 (-0.39%)
HCRF : 32.73 (+0.34%)
Healthcare ETFs in Focus Post JNJ Q4 Results

Investors should closely watch the movement of the JNJ following Q4 results and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.

XLV : 84.12 (-0.41%)
VHT : 157.88 (-0.28%)
JNJ : 129.91 (-0.73%)
IHE : 152.04 (-0.24%)
IYH : 177.81 (-0.39%)
HCRF : 32.73 (+0.34%)
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 42.89 (-0.12%)
JNJ : 129.91 (-0.73%)
MRK : 54.55 (-0.78%)
PJP : 65.66 (+0.11%)
IHE : 152.04 (-0.24%)
LLY : 77.55 (unch)
PPH : 59.68 (-0.07%)
PFE : 35.76 (-0.69%)
BMY : 66.53 (-1.22%)
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 42.89 (-0.12%)
JNJ : 129.91 (-0.73%)
MRK : 54.55 (-0.78%)
PJP : 65.66 (+0.11%)
IHE : 152.04 (-0.24%)
LLY : 77.55 (unch)
PPH : 59.68 (-0.07%)
PFE : 35.76 (-0.69%)
BMY : 66.53 (-1.22%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 42.89 (-0.12%)
PJP : 65.66 (+0.11%)
IHE : 152.04 (-0.24%)
PPH : 59.68 (-0.07%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 42.89 (-0.12%)
PJP : 65.66 (+0.11%)
IHE : 152.04 (-0.24%)
PPH : 59.68 (-0.07%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.89 (-0.12%)
JNJ : 129.91 (-0.73%)
MRK : 54.55 (-0.78%)
IHE : 152.04 (-0.24%)
PJP : 65.66 (+0.11%)
LLY : 77.55 (unch)
PFE : 35.76 (-0.69%)
BMY : 66.53 (-1.22%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.89 (-0.12%)
JNJ : 129.91 (-0.73%)
MRK : 54.55 (-0.78%)
IHE : 152.04 (-0.24%)
PJP : 65.66 (+0.11%)
LLY : 77.55 (unch)
PFE : 35.76 (-0.69%)
BMY : 66.53 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 155.62
1st Resistance Point 153.83
Last Price 152.04
1st Support Level 151.14
2nd Support Level 150.24

See More

52-Week High 166.06
Fibonacci 61.8% 156.78
Fibonacci 50% 153.91
Last Price 152.04
Fibonacci 38.2% 151.04
52-Week Low 141.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.